VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 26 filers reported holding VASCULAR BIOGENICS LTD in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,533 | +39.6% | 39,000 | 0.0% | 0.00% | – |
| Q4 2022 | $4,680 | -22.0% | 39,000 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -90.5% | 39,000 | 0.0% | 0.00% | – |
| Q2 2022 | $63,000 | -4.5% | 39,000 | 0.0% | 0.00% | – |
| Q1 2022 | $66,000 | -14.3% | 39,000 | 0.0% | 0.00% | – |
| Q4 2021 | $77,000 | +51.0% | 39,000 | +56.0% | 0.00% | – |
| Q3 2021 | $51,000 | -15.0% | 25,000 | 0.0% | 0.00% | – |
| Q2 2021 | $60,000 | +20.0% | 25,000 | 0.0% | 0.00% | – |
| Q1 2021 | $50,000 | +6.4% | 25,000 | 0.0% | 0.00% | – |
| Q4 2020 | $47,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,771 | $2,063,000 | 2.12% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $230,000 | 0.14% |
| 683 Capital Management, LLC | 400,000 | $920,000 | 0.08% |
| DLD Asset Management, LP | 244,500 | $555,000 | 0.05% |
| ARK Investment Management | 75,354 | $173,000 | 0.01% |
| Virtu Financial LLC | 68,222 | $157,000 | 0.01% |
| IFP Advisors, Inc | 19,567 | $139,000 | 0.01% |
| FIDUCIARY TRUST INTERNATIONAL LLC | 11,050 | $25,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 19,614 | $43,000 | 0.00% |
| A.R.T. Advisors, LLC | 37,782 | $86,000 | 0.00% |